Skip to main content

Animations

MJFF Publications

5891 - 5900 of 6456 Results
Title
Year
  • Year
  • 2023
  • 2025
  • 2016
  • 2023
  • 2019
  • 2023
  • 2017
  • 2007
  • 2016
  • 2014
  • Summary Details
    OPEN
    Title: Ethnicity and Parkinson’s Disease: Motor and Nonmotor Features and Disease Progression in Latino Patients Living in Rural California
    Journal Name: The Journals of Gerontology: Series A
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1093/gerona/glad016
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Gut microbiome-derived tryptophan metabolites predict relapse in alcohol use disorder
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbi.2025.106161
    Citation Count: 0
  • LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies
    2016
    Summary Details
    OPEN
    Title: LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26892
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad192
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs
    Journal Name: Clinical Pharmacology & Therapeutics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/cpt.1634
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.3c00437
    Citation Count: 20
  • Summary Details
    OPEN
    Title: TMEM230 in Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.03.014
    Citation Count: 9
  • Summary Details
    OPEN
    Title: TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2006.11.012
    Citation Count: 181
  • Summary Details
    OPEN
    Title: Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nicl.2016.02.012
    Citation Count: 80
  • Summary Details
    OPEN
    Title: Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.05.012
    Citation Count: 34
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.